Navann Ty
Stock Analyst at Exane BNP Paribas
(3.21)
# 2,477
Out of 4,531 analysts
39
Total ratings
55.6%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Navann Ty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OGN Organon & Co. | Downgraded: Hold | $15 → $14 | $13.52 | +3.55% | 6 | Apr 28, 2026 | |
| MDLN Medline | Initiated Coverage: Hold | $38 | $39.79 | -4.50% | 1 | Jan 12, 2026 | |
| NTRA Natera | Upgraded: Hold | $28 → $172 | $271.39 | -36.62% | 2 | Oct 27, 2025 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $92 | $63.07 | +45.87% | 1 | Sep 10, 2025 | |
| PAHC Phibro Animal Health | Maintained: Hold | $24 → $37 | $33.31 | +11.08% | 2 | Sep 4, 2025 | |
| COO The Cooper Companies | Upgraded: Buy | $92 | $71.71 | +28.29% | 1 | Jul 22, 2025 | |
| KVUE Kenvue | Initiated Coverage: Hold | $28 | $18.98 | n/a | 1 | May 30, 2023 | |
| SKIN SkinHealth Systems | Upgraded: Hold | n/a | $0.8438 | n/a | 2 | Mar 20, 2023 | |
| ABBV AbbVie | Initiated Coverage: Hold | $169 | $254.49 | n/a | 1 | Dec 8, 2022 | |
| EOLS Evolus | Initiated Coverage: Buy | $13 | $5.73 | n/a | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $52.72 | n/a | 2 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $11 | $17.29 | n/a | 2 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $232 → $208 | $76.56 | n/a | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $200 | $247.53 | n/a | 1 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $42 | $25.83 | n/a | 6 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.42 → $51.83 | $6.78 | n/a | 3 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 | $32.03 | n/a | 1 | Apr 24, 2020 |
Organon & Co.
Apr 28, 2026
Downgraded: Hold
Price Target: $15 → $14
Current: $13.52
Upside: +3.55%
Medline
Jan 12, 2026
Initiated Coverage: Hold
Price Target: $38
Current: $39.79
Upside: -4.50%
Natera
Oct 27, 2025
Upgraded: Hold
Price Target: $28 → $172
Current: $271.39
Upside: -36.62%
GE HealthCare Technologies
Sep 10, 2025
Reiterated: Buy
Price Target: $92
Current: $63.07
Upside: +45.87%
Phibro Animal Health
Sep 4, 2025
Maintained: Hold
Price Target: $24 → $37
Current: $33.31
Upside: +11.08%
The Cooper Companies
Jul 22, 2025
Upgraded: Buy
Price Target: $92
Current: $71.71
Upside: +28.29%
Kenvue
May 30, 2023
Initiated Coverage: Hold
Price Target: $28
Current: $18.98
Upside: n/a
SkinHealth Systems
Mar 20, 2023
Upgraded: Hold
Price Target: n/a
Current: $0.8438
Upside: n/a
AbbVie
Dec 8, 2022
Initiated Coverage: Hold
Price Target: $169
Current: $254.49
Upside: n/a
Evolus
Dec 8, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $5.73
Upside: n/a
Mar 22, 2022
Maintained: Hold
Price Target: $22 → $26
Current: $52.72
Upside: n/a
Mar 10, 2022
Maintained: Hold
Price Target: $16 → $11
Current: $17.29
Upside: n/a
Mar 9, 2022
Maintained: Hold
Price Target: $232 → $208
Current: $76.56
Upside: n/a
Oct 5, 2021
Initiated Coverage: Buy
Price Target: $200
Current: $247.53
Upside: n/a
May 17, 2021
Maintained: Buy
Price Target: $39 → $42
Current: $25.83
Upside: n/a
Mar 2, 2021
Maintained: Buy
Price Target: $36.42 → $51.83
Current: $6.78
Upside: n/a
Apr 24, 2020
Initiated Coverage: Hold
Price Target: $10
Current: $32.03
Upside: n/a